2016-12-10T02-17-59Z
Source: Indo American Journal of Pharmaceutical Research
K. Sai Supraja, Ayemen Almeen, Mariya Kauser, Aiswarya Roy .P, Sarvan Kumar .G, Surender .N.
Chronic renal failure is a slow progressive loss of kidney function over a period of several years. The main role of the kidneys is to remove wastes and excess water from the body. Chronic kidney disease (CKD) slowly gets worse over months or years. The loss of function may be so slow that may not have symptoms until kidneys have almost stopped working. Chronic kidney disease is much more common than people realize, and often goes undetected and undiagnosed until the disease is well advanced and kidney failure is fairly imminent. As kidney failure advances and the organ's function is seriously impaired, dangerous levels of waste and fluid can rapidly build up in the body. Treatment is aimed at stopping or slowing down the progression of the disease - this is usually done by controlling its underlying cause.The final stage of CKD is called end stage renal disease (ESRD) and renal transplant. Eventually the patient has permanent kidney failure patients with chronic kidney disease have multiple co - morbidities and require complicated therapeutic regimen. Clinical pharmacists specifically manage lab tests, follow up, adapt drug dosage according to guidelines and evaluate cardiovascular risk factors and decline in renal function. The purpose of the study was to summarize the available evidence regarding the role and impact of clinical pharmacy services for these patient populations. The ultimate goal of intervention in patients with chronic kidney failure is to improve the quality of life of patients.
http://ift.tt/2hhVjjt
Σάββατο 10 Δεκεμβρίου 2016
CLINICAL PHARMACIST INTERVENTION IN THE MANAGEMENT OF PATIENTS WITH CHRONIC RENAL FAILURE
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Vol.30 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nItCSB via IFTTT
-
Background Although pneumonia is a leading cause of death in New York City (NYC), limited data exist about the settings in which pneumonia ...
-
Summary We tested whether prophylactic droperidol and ondansetron, in combination with a moderate dose of dexamethasone, were equally effe...
-
by Demin Li, Carol Bentley, Jenna Yates, Maryam Salimi, Jenny Greig, Sarah Wiblin, Tasneem Hassanali, Alison H. Banham Therapeutic monoclon...
-
Vol.69 No.3 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ltDWNq via IFTTT
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1HDudvw via IFTTT
-
Abstract Dermoscopy has demonstrated clinical benefits in improving early melanoma diagnosis and reducing unnecessary biopsies. Despite th...
-
by Sarah K. Sharman, Bianca N. Islam, Yali Hou, Margaux Usry, Allison Bridges, Nagendra Singh, Subbaramiah Sridhar, Satish Rao, Darren D. Br...
-
ACS Nano DOI: 10.1021/acsnano.6b08567 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oNpdhD via...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου